US Stock MarketDetailed Quotes

KYTX Kyverna Therapeutics

Watchlist

4.040
+0.080+2.02%

Trading Dec 26 11:20 ET

174.41MMarket Cap-1.58P/E (TTM)

Kyverna Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Kyverna Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q1	-- / 0.000	--
--	2024/Q4	-- / 0.000	--
--	2024/Q3	0.000 / 0.000	--
--	2024/Q2	0.000 / 0.000	--
--	2024/Q1	0.000 / 0.000	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q1-- / 0.000--

--2024/Q4-- / 0.000--

--2024/Q30.000 / 0.000--

--2024/Q20.000 / 0.000--

--2024/Q10.000 / 0.000--

Unlock Free Earnings Estimates

Open Account

Kyverna Therapeutics Earnings Reports

Kyverna Therapeutics | 10-Q: Q3 2024 Earnings Report

Nov 13 16:28 ET

Kyverna Therapeutics | 8-K: Kyverna Therapeutics Provides Business Update and Reports Third Quarter 2024 Financial Results

Nov 13 16:23 ET

Kyverna Therapeutics | 10-Q: Quarterly report

Aug 12 16:22 ET

Kyverna Therapeutics | 8-K: Kyverna Therapeutics Provides Business Update and Reports Second Quarter 2024 Financial Results

Aug 12 16:18 ET

Analyst Rating

Updated: Dec 26, 2024

Strong Buy

Buy
83.33%
Hold
16.67%
Sell
0.00%

Price Target

No Data

Heat List

Overall